# ENLIGHT-AML - An Open-label, Study of GB3226 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

> clinical trial · VERIFIED · 2026-07-06

Status: WITHDRAWN · Sponsor: Galecto Biotech AB · Condition: Relapsed/Refractory Acute Myeloid Leukemia (AML)

- Company: Galecto Biotech AB
- Sector: Relapsed/Refractory Acute Myeloid Leukemia (AML)
- Primary source: https://clinicaltrials.gov/study/NCT07084584

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.